By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Navidea Biopharmaceuticals 

425 Metro Place Northurt
Suite 400
Dublin  Ohio  43017  U.S.A.
Phone: 614-793-7500 Fax: 614 793 7520


SEARCH JOBS


Industry
Medical Device






Company News
Navidea (NAVB) Reports First Quarter 2015 Financial Results; Reiterates 2015 Lymphoseek Revenue Guidance 5/12/2015 11:26:47 AM
Navidea (NAVB) Secures $60 Million Loan 5/11/2015 4:03:39 PM
Navidea (NAVB) To Announce First Quarter 2015 Financial Results On May 12, 2015 5/1/2015 9:42:40 AM
Navidea (NAVB) To Announce First Quarter 2015 Financial Results On May 12, 2015 4/30/2015 12:54:23 PM
EXCLUSIVE: Navidea (NAVB) CEO Tells BioSpace (DHX) New Cancer Treatment Will See More Trial Data in 2015 4/28/2015 6:35:26 AM
Navidea Biopharmaceuticals (NAVB) Divests NAV5001, A Non-Core, Development-Stage Imaging Agent For Parkinson's Disease 4/27/2015 11:14:45 AM
Navidea Biopharmaceuticals (NAVB) Data For Manocept CD206 Targeting Platform Demonstrate Potential To Impact Tumor-Associated Macrophages And Kaposi‚Äôs Sarcoma Tumor Cells 4/22/2015 10:26:53 AM
Navidea Biopharmaceuticals (NAVB) Announces Lymphoseek Presentations At Upcoming Medical Conferences 4/15/2015 6:33:43 AM
Navidea Biopharmaceuticals (NAVB) Announces Presentation Of Lymphoseek Data At Society Of Surgical Oncology Meeting 3/25/2015 10:32:44 AM
Macrophage Therapeutics, A Subsidiary Of Navidea Biopharmaceuticals (NAVB), Executes Securities Purchase Agreement For $2.5 Million Financing And Receives Initial Funding 3/16/2015 10:59:31 AM
12345678910...
//-->